Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers identify HSP90A inhibitors

May 25, 2022

Sitryx Therapeutics describes new NFE2L2 activators

May 25, 2022

Shanghai Blueray Biopharma discloses PTPN11 mutant inhibitors

May 25, 2022

Adorx Therapeutics patents new CD73 inhibitors

May 25, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Boehringer Ingelheim Pharma KG identifies new EGFR mutant inhibitors

May 24, 2022

Follicum AB and University of Bradford disclose compounds for skin and hair disorders

May 24, 2022

Idorsia Pharmaceuticals patents new LGALS3 inhibitors

May 24, 2022

Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors

May 24, 2022

New PROTACs developed by Luzhou Baicaotang Chinese Traditional Medicine

May 23, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...